Total Payments
$5,103
2024 Payments
$631.80
Companies
46
Transactions
333
Medicare Patients
8,207
Medicare Billing
$897,562
Payment Breakdown by Category
Food & Beverage$5,089 (99.7%)
Education$13.89 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,089 | 332 | 99.7% |
| Education | $13.89 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $673.65 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $641.38 | 35 | $0 (2024) |
| PFIZER INC. | $368.89 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $328.99 | 30 | $0 (2022) |
| Lilly USA, LLC | $326.45 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $301.62 | 24 | $0 (2021) |
| ABBVIE INC. | $264.16 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $220.98 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $214.00 | 12 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $199.40 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $631.80 | 31 | AstraZeneca Pharmaceuticals LP ($183.62) |
| 2023 | $652.43 | 34 | AstraZeneca Pharmaceuticals LP ($146.65) |
| 2022 | $694.33 | 41 | AstraZeneca Pharmaceuticals LP ($130.85) |
| 2021 | $826.02 | 58 | Janssen Pharmaceuticals, Inc ($115.78) |
| 2020 | $690.29 | 45 | Novo Nordisk Inc ($166.95) |
| 2019 | $399.72 | 28 | PFIZER INC. ($46.52) |
| 2018 | $506.80 | 40 | GlaxoSmithKline, LLC. ($113.95) |
| 2017 | $701.13 | 56 | GlaxoSmithKline, LLC. ($130.65) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/14/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Analgesic | ||||||
| 11/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: VACCINES | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.01 | General |
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.08 | General |
| 08/27/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: UROLOGY | ||||||
| 07/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 06/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: VACCINES | ||||||
| 06/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.80 | General |
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Obesity | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.26 | General |
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.13 | General |
| 04/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA | Food and Beverage | In-kind items and services | $53.03 | General |
| Category: Respiratory | ||||||
| 04/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Oncology | ||||||
| 04/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Cardio-renal | ||||||
| 02/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,951 | 3,634 | $476,276 | $236,625 |
| 2022 | 24 | 2,018 | 3,784 | $449,870 | $229,564 |
| 2021 | 22 | 2,059 | 3,887 | $459,741 | $234,453 |
| 2020 | 29 | 2,179 | 3,925 | $459,604 | $196,920 |
Total Patients
8,207
Total Services
15,230
Medicare Billing
$897,562
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 450 | 1,354 | $257,388 | $114,322 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 306 | 306 | $64,168 | $39,789 | 62.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 66 | 66 | $21,120 | $18,383 | 87.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 178 | 276 | $34,776 | $16,385 | 47.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 209 | 214 | $21,240 | $16,179 | 76.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 214 | 218 | $10,820 | $6,767 | 62.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 64 | 77 | $8,470 | $4,450 | 52.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $12,402 | $3,848 | 31.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $6,018 | $3,788 | 62.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 68 | 69 | $3,070 | $2,142 | 69.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 13 | $3,042 | $2,139 | 70.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 210 | $10,080 | $2,116 | 21.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 91 | 91 | $2,730 | $1,714 | 62.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 32 | $7,605 | $1,628 | 21.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 15 | 19 | $2,850 | $988.92 | 34.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 26 | $1,248 | $455.04 | 36.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 45 | $1,215 | $428.40 | 35.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 38 | $3,876 | $382.63 | 9.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 44 | 379 | $1,895 | $300.14 | 15.8% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 13 | 13 | $715.00 | $229.97 | 32.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 19 | 48 | $288.00 | $154.08 | 53.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 17 | 84 | $1,260 | $36.92 | 2.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 476 | 1,356 | $257,841 | $115,590 | 44.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 336 | 336 | $60,716 | $44,610 | 73.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 241 | 245 | $19,600 | $17,175 | 87.6% |
About Dr. Melchor Sipalay, MD
Dr. Melchor Sipalay, MD is a Internal Medicine healthcare provider based in Pueblo, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356390074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melchor Sipalay, MD has received a total of $5,103 in payments from pharmaceutical and medical device companies, with $631.80 received in 2024. These payments were reported across 333 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($5,089).
As a Medicare-enrolled provider, Sipalay has provided services to 8,207 Medicare beneficiaries, totaling 15,230 services with total Medicare billing of $897,562. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pueblo, CO
- Active Since 05/09/2006
- Last Updated 04/28/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356390074
Products in Payments
- FARXIGA (Drug) $364.40
- ELIQUIS (Drug) $363.19
- XARELTO (Drug) $287.75
- Ozempic (Drug) $266.64
- Kerendia (Drug) $220.98
- Victoza (Drug) $140.07
- STIOLTO RESPIMAT (Drug) $127.40
- ANORO (Drug) $124.53
- ZTLido (Drug) $113.99
- JANUVIA (Drug) $101.73
- SHINGRIX (Biological) $99.98
- BREZTRI (Drug) $95.12
- Rybelsus (Drug) $92.20
- VRAYLAR (Drug) $79.81
- UBRELVY (Drug) $77.94
- TRULICITY (Drug) $77.90
- BASAGLAR (Drug) $72.89
- GEMTESA (Drug) $72.12
- ENTRESTO (Drug) $72.10
- INSPIRE (Device) $71.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pueblo
Bhavith Aruni Babu
Internal Medicine — Payments: $52,390
Internal Medicine $52,390
Derar Albashaireh, M.b.b.s, M.B.B.S
Internal Medicine — Payments: $9,784
Internal Medicine $9,784
Alonso Pacheco, Md, MD
Internal Medicine — Payments: $8,199
Internal Medicine $8,199
Dr. Raj Vashistha, Md, MD
Internal Medicine — Payments: $5,402
Internal Medicine $5,402
Megan Reichmuth, D.o, D.O
Internal Medicine — Payments: $5,237
Internal Medicine $5,237
George Birks, M.d, M.D
Internal Medicine — Payments: $4,796
Internal Medicine $4,796